CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $248.31M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 2.74: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.95%Above 5Y avg (2.49%)
Annual Rate
JPY 40.00Paid semi-annual
Payout Ratio
37.2%Sustainable
Next Ex-Dividend
Nov 27, 2026
The reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2026, balance sheet FY2025, cash-flow statement FY2025. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
39.34BJPY248.31M · vs all stocks (USD)
Trailing P/E
12.39xRevenue (TTM)
50.65BJPY319.68M · vs all stocks (USD)
Profit Margin
6.24%Beta
0.1920xvs all stocks
52-Week Change
6.85%vs all stocks
Forward Annual Dividend Yield
2.95%vs all stocks
Market Capitalization
39.34BJPY248.31M · vs all stocks (USD)
Enterprise Value
46.76BJPY295.12M · vs all stocks (USD)
Trailing P/E
12.39xForward P/E
6.17xPEG Ratio
-0.2326xPrice to Sales (TTM)
0.7432xPrice to Book (MRQ)
0.7239xEnterprise to Revenue
0.9230xEnterprise to EBITDA
5.83xProfit Margin
6.24%Operating Margin
6.35%Return on Assets (TTM)
3.00%Return on Equity (TTM)
5.97%Revenue (TTM)
50.65BJPY319.68M · vs all stocks (USD)
Revenue per Share (TTM)
1.72KJPYUpdated Aug 20, 2026Quarterly Revenue Growth
-0.80%Gross Profit (TTM)
9.90BJPY62.47M · vs all stocks (USD)
EBITDA (TTM)
8.02BJPY50.64M · vs all stocks (USD)
Net Income (TTM)
3.16BJPY19.95M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
29.40%Operating Cash Flow (TTM)
9.38BJPY59.18M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.27BJPY14.35M · vs all stocks (USD)
Forward Annual Dividend Rate
40.00JPYUpdated Aug 20, 2026Forward Annual Dividend Yield
2.95%vs all stocks
Trailing Annual Dividend Rate
40.00JPYUpdated Aug 20, 2026Trailing Annual Dividend Yield
2.95%vs all stocks
5-Year Average Dividend Yield
2.49%vs all stocks
Payout Ratio
37.21%Minority Interest (Equity)
64.00MJPYFY2025 · May 31, 2025EPS (Basic)
107.49JPYFY2026 · May 31, 2026EPS (Diluted)
107.49JPYFY2026 · May 31, 2026Basic Shares Outstanding
29.41MSharesFY2026 · May 31, 2026Diluted Shares Outstanding
29.41MSharesFY2026 · May 31, 2026Operating Cash Flow
2.57BJPYFY2025 · May 31, 2025Free Cash Flow
-4.22BJPYFY2025 · May 31, 2025Cash & Cash Equivalents (End of Period)
2.21BJPYFY2025 · May 31, 2025Starting Profit (CF Statement)
2.96BJPYFY2025 · May 31, 2025Other Non-cash Items
2.09BJPYFY2025 · May 31, 2025Change in Accounts Receivable (CF)
-4.89BJPYFY2025 · May 31, 2025Change in Other Assets/Liabilities
2.42BJPYFY2025 · May 31, 2025Capital Expenditures
-6.79BJPYFY2025 · May 31, 2025Net Intangibles (CF)
-241.00MJPYFY2025 · May 31, 2025Net Acquisitions
-707.00MJPYFY2025 · May 31, 2025Purchase of Investments
-6.00MJPYFY2025 · May 31, 2025Sale of Investments
444.00MJPYFY2025 · May 31, 2025Other Investing Activity
-66.00MJPYFY2025 · May 31, 2025Net Investing Cash Flow
-7.12BJPYFY2025 · May 31, 2025Long-term Debt Issuance
6.00BJPYFY2025 · May 31, 2025Long-term Debt Payments
-3.10BJPYFY2025 · May 31, 2025Common Stock Repurchase
-623.00MJPYFY2025 · May 31, 2025Common Dividends Paid
-998.00MJPYFY2025 · May 31, 2025Other Financing Charges
-2.00MJPYFY2025 · May 31, 2025Net Financing Cash Flow
1.28BJPYFY2025 · May 31, 2025Shares Outstanding
29.49MSharesUpdated Aug 20, 2026Float Shares
25.44MSharesUpdated Aug 20, 2026% Held by Insiders
16.14%vs all stocks
% Held by Institutions
32.75%vs all stocks
Total Cash (MRQ)
954.00MJPY6.02M · vs all stocks (USD)
Total Cash per Share (MRQ)
33.19JPYUpdated Aug 20, 2026Total Debt (MRQ)
9.29BJPY58.66M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1756xCurrent Ratio (MRQ)
2.62xBook Value per Share (MRQ)
1.84KJPYUpdated Aug 20, 2026Total Assets
78.00BJPY492.31M · vs all stocks (USD)
Total Current Assets
41.71BJPYFY2025 · May 31, 2025Total Liabilities
25.94BJPYFY2025 · May 31, 2025Total Non-current Assets
36.29BJPYFY2025 · May 31, 2025Total Non-current Liabilities
8.89BJPYFY2025 · May 31, 2025Total Current Liabilities
17.05BJPYFY2025 · May 31, 2025Cash & Cash Equivalents
2.21BJPYFY2025 · May 31, 2025Accounts Receivable
12.67BJPYFY2025 · May 31, 2025Inventory
18.41BJPYFY2025 · May 31, 2025Accounts Payable
4.68BJPYFY2025 · May 31, 2025Short-term Debt
3.46BJPYFY2025 · May 31, 2025Other Current Liabilities
4.48BJPYFY2025 · May 31, 2025Long-term Debt
8.43BJPYFY2025 · May 31, 2025Other Non-current Liabilities
224.00MJPYFY2025 · May 31, 2025Common Stock (Book)
7.19BJPYFY2025 · May 31, 2025Retained Earnings
37.18BJPYFY2025 · May 31, 2025Total Shareholders' Equity
52.07BJPY328.63M · vs all stocks (USD)
Treasury Stock
749.00MJPYFY2025 · May 31, 202552-Week Low
1.12KJPYUpdated Aug 20, 202652-Week High
1.52KJPYUpdated Aug 20, 202652-Week Change
6.85%vs all stocks
Beta
0.1920xvs all stocks
50-Day MA
1.25KJPYUpdated Aug 20, 2026200-Day MA
1.31KJPYUpdated Aug 20, 2026Avg 10-Day Volume
54.69KSharesUpdated Aug 20, 2026Avg 30-Day Volume
74.30KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
107.47JPYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.74: safe zoneNotable
Altman Z-Score: 2.74
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $248.31M, lower than 95% of all stocks globallySignificant
Market cap (USD): 248,309,522.298Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Siga Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sisram Medical Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Heartseed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Fulcrum Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Jiaying Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Surrozen, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tiansheng Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Greenwich LifeSciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Seikagaku Corporation
Tier 1ProductionApproval-Gated PipelineRule